Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
在人源小鼠肿瘤模型中,靶向 p53 缺陷型三阴性乳腺癌中的 Chk1 具有治疗益处。
期刊:Journal of Clinical Investigation
影响因子:13.3
doi:10.1172/JCI58765
Cynthia X Ma ,Shirong Cai, Shunqiang Li, Christine E Ryan, Zhanfang Guo, W Timothy Schaiff, Li Lin, Jeremy Hoog, Reece J Goiffon, Aleix Prat, Rebecca L Aft, Matthew J Ellis, Helen Piwnica-Worms